QQ客服 官方微博 反馈留言

	Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine
	Lu, Quanyi ; Lu QY(鹿全意) ; Chen, Yamei ; Li, Zhipeng
	2012-06
英文摘要	Myelofibrosis (MF) is a frequent complication of hematological malignancy. It has been reported that any French-American-British (FAB) subtype of acute myelogenous leukemia (AML) may be complicated by fibrosis, and the severity of fibrosis has been associated with poor prognosis [1]. Acute promyelocytic leukemia (APL), a subtype FAB-M3, has a good prognosis with all-trans retinoic acid (ATRA), and a few cases of severe marrow fibrosis in APL patients have been reported to date and all achieved molecular remission [2], [3], [4] and [5]. However, as far as we know, its prognostic significance has not yet been established and it is uncertain whether MF can affect the response to arsenic trioxide (ATO) treatment on patients with APL. Bone marrow (BM) fibrosis probably occurs secondary to the activation of normal fibroblasts by cytokines secreted from leukemic cells. For example, the transforming growth factor β (TGF-β), a cytokine correlated with MF, promotes collagen synthesis and fibroblast proliferation in the BM [5] and [6]. Here, we report a case of an APL patient with severe MF who achieved molecular remission with the ATO treatment. We also made a series of molecular studies to try to clarify the mechanism of MF in APL.
语种	英语
出版者	PERGAMON-ELSEVIER SCIENCE LTD
内容类型	期刊论文
源URL	[http://dx.doi.org/10.1016/j.leukres.2012.02.004]
专题	医学院－已发表论文
推荐引用方式 GB/T 7714	Lu, Quanyi,Lu QY,Chen, Yamei,et al. Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine[J],2012.
APA	Lu, Quanyi,鹿全意,Chen, Yamei,&Li, Zhipeng.(2012).Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine..
MLA	Lu, Quanyi,et al."Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine".(2012).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。